A Clinical Study to Evaluate of Single and Multiple Oral Doses of GM-1020 in Patients With MDD

Clinical trial NCT06309277 · COMPLETED

Trial details

NCT number: NCT06309277
Sponsor: Gilgamesh Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2024-02-01
Primary completion: 2025-03-04
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.